ArticlePDF Available

Changes in steady-state concentrations of messenger ribonucleic acids in luteal tissue during prostaglandin F2α induced luteolysis in mares

Authors:

Abstract and Figures

Transvaginal ultrasound-guided luteal biopsy was used to evaluate the effects of prostaglandin (PG)F2alpha on steady-state concentrations of mRNA for specific genes that may be involved in regression of the corpus luteum (CL). Eight days after ovulation (Hour 0), mares (n=8/group) were randomized into three groups: control (no treatment or biopsy), saline+biopsy (saline treatment at Hour 0 and luteal biopsy at Hour 12), or PGF2alpha+biopsy (5mg PGF2alpha at Hour 0 and luteal biopsy at Hour 12). The effects of biopsy on CL were compared between the controls (no biopsy) and saline+biopsy group. At Hour 24 (12h after biopsy) there was a decrease in circulating progesterone in saline group to 56% of pre-biopsy values, indicating an effect of biopsy on luteal function. Mean plasma progesterone concentrations were lower (P<0.001) at Hour 12 in the PG group compared to the other two groups. The relative concentrations of mRNA for different genes in luteal tissue at Hour 12 was quantified by real time PCR. Compared to saline-treated mares, treatment with PGF2alpha increased mRNA for cyclooxygenase-2 (Cox-2, 310%, P<0.006), but decreased mRNA for LH receptor to 44% (P<0.05), steroidogenic acute regulatory protein to 22% (P<0.001), and aromatase to 43% (P<0.1) of controls. There was no difference in mRNA levels for PGF2alpha receptor between PG and saline-treated groups. Results indicated that luteal biopsy alters subsequent luteal function. However, the biopsy approach was effective for collecting CL tissue for demonstrating dynamic changes in steady-state levels of mRNAs during PGF2alpha-induced luteolysis. Increased Cox-2 mRNA concentrations suggested that exogenous PGF2alpha induced the synthesis of intraluteal PGF2alpha. Thus, the findings are consistent with the concept that an intraluteal autocrine loop augments the luteolytic effect of uterine PGF2alpha in mares.
Content may be subject to copyright.
Animal Reproduction Science 90 (2005) 273–285
Changes in steady-state concentrations of messenger
ribonucleic acids in luteal tissue during
prostaglandin F2induced luteolysis in mares
M.A. Bega,c, E.L. Gastala,c, M.O. Gastala,c,
S. Jib, M.C. Wiltbankb, O.J. Ginthera,c,
aDepartment of Animal Health and Biomedical Sciences, 1656 Linden Drive,
University of Wisconsin-Madison, WI 53706, USA
bDepartment of Dairy Science, University of Wisconsin-Madison, WI 53706,USA
cThe Eutheria Foundation, Cross Plains, WI 53528, USA
Received 18 January 2005; received in revised form 16 February 2005; accepted 28 February 2005
Available online 11 April 2005
Abstract
Transvaginal ultrasound-guided luteal biopsy was used to evaluate the effects of prostaglandin
(PG)F2onsteady-stateconcentrationsofmRNAforspecificgenes that may be involvedinregression
of the corpus luteum (CL). Eight days after ovulation (Hour 0), mares (n= 8/group) were randomized
into three groups: control (no treatment or biopsy), saline+ biopsy (saline treatment at Hour 0 and
luteal biopsy at Hour 12), or PGF2+ biopsy (5mg PGF2at Hour 0 and luteal biopsy at Hour 12).
The effects of biopsy on CL were compared between the controls (no biopsy) and saline+biopsy
group. At Hour 24 (12h after biopsy) there was a decrease in circulating progesterone in saline
group to 56% of pre-biopsy values, indicating an effect of biopsy on luteal function. Mean plasma
progesterone concentrations were lower (P<0.001) at Hour 12 in the PG group compared to the
other two groups. The relative concentrations of mRNA for different genes in luteal tissue at Hour 12
was quantified by real time PCR. Compared to saline-treated mares, treatment with PGF2increased
mRNA for cyclooxygenase-2 (Cox-2, 310%, P< 0.006), but decreased mRNA for LH receptor to 44%
(P< 0.05), steroidogenic acute regulatory protein to 22% (P<0.001), and aromatase to 43% (P<0.1)
of controls. There was no difference in mRNA levels for PGF2receptor between PG and saline-
treated groups. Results indicated that luteal biopsy alters subsequent luteal function. However, the
Corresponding author. Tel.: +1 608 262 107; fax: +1 608 262 7420.
E-mail address: ojg@ahabs.wisc.edu (O.J. Ginther).
0378-4320/$ see front matter © 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.anireprosci.2005.02.008
274 M.A. Beg et al. / Animal Reproduction Science 90 (2005) 273–285
biopsy approach was effective for collecting CL tissue for demonstrating dynamic changes in steady-
state levels of mRNAs during PGF2-induced luteolysis. Increased Cox-2 mRNA concentrations
suggested that exogenous PGF2induced the synthesis of intraluteal PGF2. Thus, the findings are
consistent with the concept that an intraluteal autocrine loop augments the luteolytic effect of uterine
PGF2in mares.
© 2005 Elsevier B.V. All rights reserved.
Keywords: Corpus luteum; Gene regulation; Mare; Progesterone
1. Introduction
Prostaglandin (PG)F2is considered to be the luteolysin in most mammals (reviewed
in Arosh et al., 2004). Surgical removal of the uterus prolongs the life span of the cor-
pus luteum (CL) in sheep, cattle, pigs, horses and some laboratory animals, indicating that
luteolytic PGF2is of uterine/endometrial origin in these species (Wiltbank and Casida,
1956; Anderson et al., 1961; Moor and Rowson, 1966; Ginther and First, 1971). Endome-
trial PGF2reaches the CL by local, systemic, or a combination of both routes depending
on the species (Bonnin et al., 1999). In mares, several experimental approaches have in-
dicated that the pathway from uterus to ovaries for uterine-induced luteolysis is systemic
(reviewed in Ginther, 1998). In contrast, in primates including women uterine PGF2is
not the initiator of luteolysis as hysterectomy does not prolong the lifespan of CL (Neill
et al., 1969; Beling et al., 1970), and it has been postulated that autocrine and paracrine
actions of intraluteal PGF2may be involved in initiation of luteolysis (Arosh et al., 2004).
The CL of primates has the capacity to synthesize PGs, and luteal PG synthesis increases
near the time of normal luteolysis (reviewed in Wiltbank and Ottobre, 2003). Luteal PG
production also has been demonstrated in a number of species in which uterine PGF2
has a primary role in luteolysis (Wiltbank and Ottobre, 2003). In this regard, production
of PGF2by luteal tissue has been reported in cattle (Milvae and Hansel, 1983), sheep
(Rexroad and Guthrie, 1979), pigs (Guthrie et al., 1978) and horses (Watson and Sertich,
1990). Luteal PGF2increases after treatment with PGF2(Rexroad and Guthrie, 1979;
Guthrie and Rexroad, 1980; Diaz et al., 2000) consistent with a role for luteal PGF2in
regression of the CL in cattle, sheep and pigs but apparently has not been studied in horse.
The biochemical events occurring during PGF2-induced luteolysis have not been fully
described. One of the hallmarks of luteolysis is a decrease in luteal progesterone production
with an associated decrease in expression of steroidogenic acute regulatory protein (StAR).
StAR facilitates the rate-limiting step in steroidogenesis, transport of cholesterol from the
outer to inner mitochondrial membrane (Watson et al., 2000). After PGF2treatment there
is a decrease in mRNA and protein for StAR that corresponds closely to the PGF2-induced
decreaseincirculatingprogesterone(Juengel et al., 1995; Tsai et al., 2001). In contrast, treat-
ment with PGF2increases a key enzyme in the PG biosynthesis pathway, cyclooxygenase
(Cox) (Tsai and Wiltbank, 1997, 1998). The Cox enzymes catalyze the conversion of arachi-
donic acid to PGH2 which is the first committed step in PG synthesis (reviewed in Wiltbank
and Ottobre, 2003). Attention has focused on the Cox-2 isoform of the enzyme because it
M.A. Beg et al. / Animal Reproduction Science 90 (2005) 273–285 275
is highly regulated by cytokines and other growth factors (Herschman, 1994). Treatment of
sheep (Rexroad and Guthrie, 1979) and pigs (Diaz et al., 2000) with PGF2analogue in-
creased the in vitro production of PGF2by luteal tissue and dramatically increased Cox-2
expression. It has been postulated that stimulation of intraluteal Cox-2 mRNA and subse-
quentlythe Cox-2 protein could potentially initiatemechanisms within the CL for intraluteal
amplificationofthePGF2signalby producing considerable local concentrations of PGF2
(Tsai and Wiltbank, 1997). Thus, two distinct biochemical responses to PGF2result in
increased luteal PGF2production and decreased luteal progesterone production. In addi-
tion, luteal expression of aromatase was either dramatically increased (pig CL; Diaz and
Wiltbank,2004)ordecreased(miceCL; Stocco, 2004) in response to PGF2suggesting that
luteal production of estradiol may also be regulated by PGF2. The biochemical and molec-
ular events occurring in the CL during PGF2-induced luteolysis have not been studied in
mares.
Transvaginal ultrasound-guided biopsy has been used to collect CL tissue in cat-
tle (Kot et al., 1999; Tsai et al., 2001), but has not been reported in mares. The
collection of luteal samples in mares by transvaginal ultrasound-guided biopsy with
minimal disturbance to luteal function would be useful for clinical and experimental
purposes.
The objective of the present experiment was to characterize the changes in the steady-
state concentrations of five different mRNAs during PGF2-induced luteolysis in mares.
The mRNA corresponding to the enzymes involved in the rate-limiting steps in production
of progesterone (StAR), PGF2(Cox-2), and estradiol (aromatase) were chosen for anal-
ysis. In addition, the two classical receptors involved in regulating luteal function, PGF2
receptor and LH receptor (LHr), were also evaluated. It was hypothesized that in mares an
intraluteal autocrine loop augments the luteolytic effect of exogenous PGF2based on the
steady state mRNA concentrations of Cox-2. The effects of collection of luteal tissue by
transvaginal ultrasound-guided biopsy on subsequent progesterone production and size of
CL were also considered.
2. Materials and methods
2.1. Animals and groups
Animals were handled in accordance with the United States Department of Agriculture
Guide for Care and Use of Agricultural Animals in Agricultural Research. Twenty four
mares were used during the ovulatory season (May–September; Northern Hemisphere).
The mares were mixed breeds of ponies, 10–17 years of age, and weighed 300–500 kg. The
feeding program and the technique of transrectal and transvaginal ultrasound scanning have
been described (Ginther, 1995; Gastal et al., 1997). The mares were scanned by ultrasound
daily to record the day of ovulation as determined by the disappearance of a preovulatory
follicle. The treatments were given eight days after ovulation between 20:00 and 21:00h
and time of treatment was designated as Hour 0. The mares were randomized into three
groups: (1) control (no treatment); (2) saline (0.9% NaCl, 1 ml, i.m.); and (3) PGF2(1ml
Lutalyse; 5mg/ml, i.m., Pfizer Animal Health, Kalamazoo, MI, USA). Luteal biopsies
276 M.A. Beg et al. / Animal Reproduction Science 90 (2005) 273–285
were taken from saline and PG-treated mares at Hour 12 but not from the controls, using
a transvaginal ultrasound technique. The diameter and the area of the CL were recorded
in all mares at Hours 0 and 12 and then every 24h until the CL was not detectable. Blood
samples in all mares were collected from Hour 0 to Hour 36 at 12h intervals and then
every 24h until ovulation. The day of ovulation and length of interovulatory interval were
recorded.
2.2. Ultrasound-guided biopsy of CL
The CL biopsies were taken using a transvaginal ultrasound-guided technique as de-
scribed previously for cattle (Kot et al., 1999; Tsai et al., 2001). The biopsy instrument was
a 60 cm long automated spring-loaded device (US Biopsy, Franklin, IN, USA) with an inner
trocar point plunger having a 15mm notch covered by an outer 12ga cutting needle. The
automated spring loaded biopsy instrument was set to ready position so that the specimen
notch was covered by the outer cutting needle. The ovary containing the target CL was
positioned transrectally against the vaginal wall and over the face of a 5.0MHz transvagi-
nal transducer so that the CL was transected by a built-in line on the ultrasound monitor
representing the projected needle path. The biopsy instrument was introduced through the
needle channel of the transvaginal transducer. When the ovary with the CL was in position
against the vaginal wall and transducer face, the biopsy needle was inserted into the CL at
its maximum diameter. The inner plunger was advanced into the CL so that the specimen
notch was within the CL as indicated by the ultrasound image. The biopsy instrument was
fired and withdrawn. The biopsied tissue in the specimen notch was exposed by pressing
the inner plunger. Multiple biopsy attempts were done per mare during each session until
an adequate quantity of luteal tissue was obtained. Each biopsy tract was viewed on the
ultrasound image and was avoided during subsequent biopsies. A successful biopsy was
defined as a partial to full notch of CL tissue. The total mean weight of CL tissue removed
from each mare ranged from 30 to 183mg. The biopsy tissue was frozen in a tube placed
in dry ice and taken to the laboratory for weighing and processing for extraction of mRNA.
2.3. Isolation of mRNA from the CL biopsies
The detailed procedure of mRNA isolation from CL tissue using Magnetight oligo(dT)
beads (Novagen, Madison, WI, USA) has been described (Tsai and Wiltbank, 1998; Tsai
et al., 2001). Briefly, approximately 20mg of luteal tissue was homogenized in 400l lysis
buffer (4M guanidium isothiocyanate, 0.5% (w/v) sarcosyl, 100mM Tris–HCl, pH 8.0 and
1% (w/v) dithiothreitol) using a glass homogenizer. Chromosomal DNA was sheared by
passing the homogenate through a 25-gauge needle 10 times. Two volumes of binding
buffer (100mM Tris–HCl, pH 8.0, 20mM EDTA and 400mM NaCl) were added to the
homogenate. Samples were centrifuged at 16,000 ×gfor 5 min at 4 C to pellet cellular
debris. Supernatant was transferred to a tube containing oligo(dT) beads and allowed to
hybridize for 10 min. Beads were captured on a magnetic stand and washed four times with
500l wash buffer (150 mM NaCl, 10 mM Tris–HCl, pH 8.0 and 1 mM EDTA), and mRNA
was eluted with 30l elution buffer (2mM EDTA) after heating to 65C for 5min. The
mRNA was stored at 80C until used.
M.A. Beg et al. / Animal Reproduction Science 90 (2005) 273–285 277
2.4. Quantitative real-time PCR
The mRNA was quantitated using real-time reverse transcription polymerase chain re-
action (RT-PCR). The gene-specific primers were designed according to cDNA sequences
from GenBank using the Primer ExpressTM software (PE Applied Biosystems, Foster City,
CA, USA) (Table 1). The mRNA was reverse transcribed at 42 C for 1h followed by heat-
ing to 95 C for 10min and quick chilling to 4 C as described (Tsai et al., 2001). Real-time
PCR was carried out in a GeneAmp 5700 Sequence Detection System (PE Applied Biosys-
tems, Foster City, CA, USA) using the double-strand DNA-binding dye, Syber Green I
(Molecular Probes, Eugene, OR, USA) for the detection of PCR products. Two microliters
of RT product in the presence of PCR reaction mixture (1×thermophilic buffer, 1.5mM
MgCl2, 0.2mM dNTPs, 0.4 M each of forward and reverse primers, and 1 U Taq DNA
polymerase) were subjected to 40 cycles of amplification by real-time PCR (30s denat-
uration at 95 C, 30 s annealing at 57 C, and 30 s extension at 72C). The fluorescence
intensity of the Syber Green I was read after the end of each extension step. The threshold
cycle number (Ct) for each gene was generated by real-time PCR and used to quantify the
relative abundance of each mRNA. Control reactions lacking reverse transcriptase enzyme
were set up to assess any false positives but none were found. A dissociation curve was
created using the built-in melting curve program of the GeneAmp 5700 Sequence Detection
System to confirm the presence of a single PCR product. In some experiments, the real-time
PCR products were also electrophoresed on a 5% polyacrylamide gel and were confirmed
to have a single PCR product of expected size. Messenger RNA for glyceraldehyde-3 phos-
phate dehydrogenase (G3PDH) was also measured in each sample as an internal control
and to normalize the threshold cycle for each sample. The normalized threshold cycle
number, Ct, was calculated as Ct[gene]-Ct[G3PGH]. The relative abundance of the gene
of interest was then evaluated as fold change using the expression 2Ct, where the
Table 1
Sequences of primer sets used for real time RT-PCR and accession numbers of GeneBank cDNA sequences
Gene Primer sequence Species Size (bp) Accession no.
StAR For TCAACCAGGTCCTTTCGCA Mare 104 AF031696
Rev GCAAGTTGGTCTTTAACACC
Cox-2 For ATCTACCCGCCTCATATTCCT Mare 101 AB041771
Rev CGCAGCCAAATCGTGGCATAC
Aromatase For GTGCCCGAAGTCATGCCTGTC Mare 148 AJ012610
Rev GGAACCGGAGGTGGGAAATGA
PGF2receptor For CTTCGAATGGCAACATGGAAT Bovine 105 NM 181025
Rev TCCACAACAGCGTCTGGTACA
LH receptor For TTGCCACATCATCCTATTCTC Mare 122 AY271258
Rev TTCTTTTGTTGGCAAGTTTCT
G3PDH For ACCACTTTGGCATCGTGGAG Mare 76 AF157626
Rev GGGCCATCCACGGTCTTCTG
StAR, steroidogenic acute regulatory protein; Cox-2, cyclooxygenase-2; G3PDH, glyceraldehyde-3 phosphate
dehydrogenase. For, forward; Rev, reverse; and bp, base pairs. All primer sequences are from 5to 3.
278 M.A. Beg et al. / Animal Reproduction Science 90 (2005) 273–285
value of Ctwas obtained by subtracting the Ctof the lowest control sample from
each Ct.
2.5. Plasma progesterone analysis
Plasma samples were centrifuged (500 ×gfor 20 min), decanted and stored (20 C)
until assay. Progesterone concentrations in plasma samples were determined using a com-
petitive ELISA that has been described for use in cattle (Rasmussen et al., 1996) in which
the color intensity of the enzyme substrate was inversely proportional to the concentration.
The assay was validated for use with mare plasma in our laboratory. The unknown plasma
samples (200l) were ether extracted and the dried extract was dissolved in 500lof
ELISA assay buffer. Progesterone concentrations were determined in 100l of dissolved
ether extract in duplicate wells for each sample. Serial volumes of a pool of diestrous mare
plasma (100–400l) processed similarly as unknown samples resulted in a displacement
curve that was similar to the standard curve. The intraassay and interassay CVs were 7.0
and 6.1%, respectively, and the sensitivity was 0.03ng/ml.
2.6. Statistical analyses
The data for CL diameter and area and progesterone concentrations were tested for
normality with the Kolmogorov–Smirnov test; when the normality test was significant
(P< 0.05), the data were transformed by natural logarithm. The end points were analyzed
by SAS Mixed procedure (8.2 version; SAS Institute, Cary, NC, USA) with a repeated
measures statement and using mare within treatment as a random effect. Main effects
of group and hour and their interaction were determined. The differences in the relative
expression of mRNA for different genes between PG and saline groups were tested using
unpaired t-tests. A probability of P0.05 indicated that the difference was significant and
probabilities between P> 0.05, 0.1 indicated that the difference approached significance.
The results are presented as mean±S.E.M.
3. Results
One mare in the saline+ biopsy group was omitted because of a persistant CL for more
than 30 days. Six to 10 biopsy attempts were made per mare during each session and two
to eight attempts were successful. Mean number of biopsy attempts between PG and saline
Fig.1. Mean(±S.E.M.)changesin corpus luteum (CL)diameterandarea,and plasma progesterone concentrations
in mares given no treatment or biopsy (control; n=8), saline+biopsy (n= 7) or PGF2+biopsy (n=8). For CL
diameter, there was a main effect of hour (P<0.0001) and a main effect of group that approached significance
(P<0.1). For CL area, there was a main effect of hour (P<0.0001) and an interaction of group by hour that
approached significance (P< 0.08). For plasma progesterone concentrations, there were main effects of group
(P<0.0001) and hour (P<0.0001) and an interaction of group by hour (P<0.0001). An asterisk (*) indicates
first difference between the PGF2+biopsy group and control and saline+biopsy groups, and a pound mark (#)
indicates first difference between control and saline+biopsy groups.
M.A. Beg et al. / Animal Reproduction Science 90 (2005) 273–285 279
280 M.A. Beg et al. / Animal Reproduction Science 90 (2005) 273–285
groups (7.6 and 8.4 per mare, respectively) and successful biopsy attempts (5.4 and 5.6
per mare, respectively) were not significantly different between groups. The overall suc-
cess rate was 68%. The weight of the individual CL biopsies ranged from 3 to 46mg with
a total mean weight per mare of 30–183mg. Mean changes in the CL diameter and area
and plasma progesterone concentrations and results of the statistical analyses are shown
(Fig. 1). There was a main effect of hour for both CL diameter and area. The CL diameter
and area were similar between saline+ biopsy and control groups throughout the experi-
ment and among the three groups at the time of treatment (Hour 0) and biopsy (Hour 12).
Although the group effect or interaction only approached significance, the CL diameter at
Hour 36 (P< 0.04) and area at Hour 60 (P< 0.01) were smaller in PG +biopsy group than in
the control and saline+ biopsy groups. For plasma progesterone concentrations there were
significant effects of group and hour and an interaction of group by hour. Mean concen-
trations were similar among the three groups at Hour 0. The concentrations were lower
(P< 0.001) at Hour 12 in the PG group than in the other two groups. The progesterone con-
centrations were lower (P<0.009) in saline+ biopsy group at Hour 24 (12 h after biopsy)
than the controls (no biopsy) and continued to remain intermediate in saline +biopsy group
compared to control and PG+ biopsy groups. Progesterone data of individual mares in the
saline group were compared between samples collected prebiopsy (average of Hour 0 and
12 progesterone= 100% for each individual mare) and post-biopsy (saline + biopsy: Hour
24= 56.7 ±5.2%; Hour 36 =51.3±9.2%) and for control mares (Hour 24=98.3 ±3.8%;
Hour 36= 105.3±9.8%); the greatest progesterone decrease in an individual control mare
was 12% compared to decreases of 20–66% in the saline + biopsy group. The interovulatory
interval in three of the biopsied mares (18 days for each mare) was shorter than for all other
mares in the saline+ biopsy group (19–27 days). The interovulatory interval was reduced
(P<0.02) in both PG +biopsy and saline+biopsy groups (18.1±0.6 and 20.1 ±1.2 days,
respectively) compared to control group (23.1±0.8 days).
The relative abundance of mRNA for Cox-2, StAR, LHr, PGF2receptor and aromatase
are presented in Table 2. Compared to saline-treated mares, treatment with PGF2induced
a significant increase in mRNA for Cox-2, but a significant decrease in mRNA for StAR and
LHr, whereas a decrease in mRNA for aromatase approached significance. There was no
differenceinmRNAexpressionofPGF2receptorbetweenPG+biopsyandsaline+ biopsy
groups.
Table 2
Mean±S.E.M. relative expression of mRNAs for different genes in luteal tissue of mares after treatment with
saline or PGF2
mRNA Groups
Saline PGF2P-value
Cox-2 3.09 ±0.82 9.58 ±1.97 <0.006
StAR 50.04 ±10.82 11.21 ±2.95 <0.001
LH receptor 2.21 ±0.45 0.98 ±0.47 <0.04
PGF2receptor 1.52 ±0.79 2.08 ±0.87 NS
Aromatase 3.74 ±1.34 1.60 ±1.04 <0.10
Cox-2, cyclooxygenase-2; StAR, steroidogenic acute regulatory protein; and NS, non significant. All results were
calculated relative to the lowest value in the dataset for each mRNA (fold difference from the lowest value).
M.A. Beg et al. / Animal Reproduction Science 90 (2005) 273–285 281
4. Discussion
An ultrasound-guided biopsy technique previously used in cattle (Kot et al., 1999; Tsai
et al., 2001) was developed and used in this study to collect CL biopsies in mares. A
mean of eight biopsy procedures were done per mare. The technique was successful in
68% of the attempts. There was no detectable post-biopsy effect on CL diameter or area;
however, the plasma progesterone concentrations in saline-treated mares decreased after
biopsy compared to controls (no biopsy). The progesterone decrease in each mare in the
saline+ biopsy group was greater than for any mare in the control group indicating a uni-
form negative effect of the biopsy technique on progesterone concentrations. In addition,
biopsy alone (saline +biopsy group) appeared to cause a shorter interovulatory interval (20
days); 3 of 7 mares had particularly short interovulatory intervals (18 days) with indications
of premature luteal regression. In cattle (Kot et al., 1999), no detectable effect of luteal
biopsy was observed either on CL diameter or plasma progesterone concentrations and
no premature luteal regressions were observed. The use of a 12-ga biopsy instrument and
more biopsies attempts during a single session in the present study compared to an 18-ga
needle and less biopsy attempts in cattle were probably the causes of the effect of biopsy
on luteal function in the present study. These results indicated that the collection of luteal
tissue by this biopsy method would not be satisfactory for the study of the CL after biopsy.
However, as expected, at the time of biopsy (Hour 12) there was no difference in diameter
of CL among the three groups or plasma progesterone concentrations between control and
saline-treated groups.
Studies in nonequine species indicate that the first committed step in PG synthesis is
catalyzed by Cox enzyme, which converts arachidonic acid to PGH2 (Tsai and Wiltbank,
1997). This is generally considered a rate-limiting step in PG production. The CL has a
rich source of arachidonic acid stored in membrane phospholipids, and this is the primary
precursor of all PGs (reviewed in Arosh et al., 2004). Arachidonic acid is liberated from
phospholipids by cytosolic phospholipase A2 (cPLA2) and Cox-1 and 2 convert arachidonic
acid into PGH2, the common intermediate metabolite for various forms of PGs including
PGF2. The downstream enzymes (e.g., PGE and PGF synthases) catalyze the conversion
of PGH2 to PGE2 and PGF2(Arosh et al., 2004). The Cox-2 isoform is generally present
in low concentrations under normal physiological conditions (O’Neill and Ford, 1993)but
is stimulated by hormones and growth factors in a variety of cell types (Herschman, 1994).
A variety of these hormonal signals also increase activity of cPLA2 and production of
endogenous arachidonic acid but conversion of this endogenous arachidonic acid to PGs
appears to require Cox-2 enzyme (Karim et al., 1996). Treatment with PGF2dramatically
inducesCox-2mRNAinsheepCL and cattle CL and in cultured sheeplargelutealcells(Tsai
and Wiltbank, 1997; Tsai et al., 2001). Induction of intraluteal PGF2synthesis in response
to extraluteal PGF2may be critical in completion of the luteolytic process. The present
study provides previously unavailable information on the mechanism of PGF2action
during luteolysis in mares. Exogenous treatment with PGF2induced more than a three-
fold increase in luteal Cox-2 mRNA. This finding indicates that mares are similar to ovine
and bovine species in that exogenous PGF2, and presumably uterine PGF2, induces the
synthesis of intraluteal PGF2. Thus, the hypothesis of presence of an intraluteal autocrine
loop in mares was supported. Studies in other species (Tsai and Wiltbank, 1997) indicate
282 M.A. Beg et al. / Animal Reproduction Science 90 (2005) 273–285
that the intraluteal PGF2is involved in an autocrine loop to amplify and augment the
luteolytic effect of PGF2.
TheenzymeStAR has been identified in several species including mares as a rate-limiting
step in steroidogenesis (Watson et al., 2000). This protein is believed to be responsible
for transport of cholesterol from the outer to inner mitochondrial membrane. In cattle CL,
mRNA for StAR was decreased after PGF2treatment (Tsai et al., 2001). Similar decreases
in the StAR mRNA have been demonstrated in a number of species, but not in horses, during
natural or induced luteolysis (Juengel et al., 1995; Stocco and Clark, 1996; Townson et al.,
1996; Tsai et al., 2001). Treatment with PGF2in mares in the present study resulted in a
decrease in StAR mRNA in luteal tissue. The decrease in StAR mRNA was also reflected
in the decrease in concentrations of circulating progesterone after PGF2treatment. In
addition, the decrease in StAR mRNA was reflected in corresponding decreases in the
mRNA for LHr. A decrease in LHr mRNA in response to PGF2has been previously
reported in cattle (Tsai et al., 2001) and sheep (Guy et al., 1995), and this decrease may
disrupt LH-stimulated steroidogenesis during luteolysis. In mares, it has been reported that
the number of LH receptors decreased concomitantly with a decrease in serum and luteal
progesterone concentrations during natural (Roser and Evans, 1983) and PGF2-induced
(Roser et al., 1982) luteolysis.
In vivo studies showed that PGF2treatment decreased the PGF2receptor mRNA
in mid-cycle sheep CL (Juengel et al., 1996) and in early and mid-cycle cattle CL (Tsai
and Wiltbank, 1998; Tsai et al., 2001). During physiologic luteal regression, there is also
a dramatic decrease in the PGF2receptor mRNA concentration in sheep (reviewed in
Anderson et al., 2001). Similarly, treatment with PGF2in vitro decreased PGF2receptor
mRNA in ovine large luteal cells (Tsai et al., 1998). In contrast, PGF2treatment increased
PGF2receptor mRNA expression in rat CL (Olofsson et al., 1996), suggesting species
variation in regulation of PGF2receptors. However, there was no difference in expression
of PGF2receptor in the present study between saline+ biopsy and PG + biopsy treated
mares. The physiological importance of any changes in PGF2receptor expression during
luteolysis and reasons for the differences in regulation among species are not known.
In addition to progesterone, the CL produces estradiol in some species, including pigs,
mares, rodents, possums and primates (Amri et al., 1993; Duffy et al., 2000; Whale et al.,
2003; Diaz and Wiltbank, 2004; Stocco, 2004). In vivo treatment of pigs with PGF2in-
creased estradiol production by luteal tissue and this increase was closely associated with
a large increase in aromatase mRNA (Diaz and Wiltbank, 2004). The physiological role of
estradiol production in CL is not clearly understood; however, estradiol has both luteolytic
(Auletta et al., 1976; Duffy et al., 2000) and luteotropic effects (Ford and Christenson, 1991)
in pigs and other species. In rabbits, follicular estradiol is critical for luteal progesterone
production (Bill and Keys, 1983). In pigs, estradiol implants promote greater CL develop-
ment than non-implanted CL (Conley and Ford, 1989). The finding of elevated estradiol
production and increased estradiol receptor expression in regressing CL suggests a role
for estradiol in luteolysis in pigs (Diaz and Wiltbank, 2004). The failure to upregulate these
pathways in porcine Day 9 CL may be responsible, in part, for the inability of PGF2to
induce luteolysis at this time in pigs. In mares, an effect of estradiol on the luteal life span
has not been adequately studied. In contrast, aromatase mRNA was reduced by PGF2
treatment of mouse CL (Stocco, 2004) suggesting species variation in regulation of luteal
M.A. Beg et al. / Animal Reproduction Science 90 (2005) 273–285 283
aromatase expression. In the present study in mares, treatment with PGF2also decreased
luteal aromatase mRNA; the difference however only approached significance. Previous
studies using immunocytochemistry and Northern blots reported no detectable change in
aromatase protein and mRNA between mid-diestrous and pregnancy in mares (Albrecht et
al., 1997, 2001). Thus, the findings of the present study indicate differences between mares
and pigs but similarities to the mouse in patterns of mRNA expression for aromatase in
CL tissue during luteolysis. The reasons for this species difference are not known; further
studies are indicated in mares.
In summary, mares were treated with PGF2eight days after ovulation (Hour 0), and
luteal samples were collected by transvaginal ultrasound-guided biopsy at Hour 12 to
study steady-state concentrations of mRNAs during PGF2-induced luteolysis. Exogenous
PGF2caused a precipitous decrease in plasma progesterone concentrations by Hour 12 in
all mares. Study of the biopsies at Hour 12 indicated that treatment with PGF2decreased
mRNA for StAR and LH receptor and increased mRNA for Cox-2 enzyme; a decrease in
aromatase mRNA approached significance. The results indicated that in mares exogenous
PGF2, and presumably uterine PGF2, induces the synthesis of intraluteal PGF2and are
compatible with the establishment of an intraluteal autocrine loop to amplify and augment
the luteolytic effect of PGF2.
Acknowledgements
This work was supported by the Eutheria Foundation (Cross Plains, WI). Project (P1-
MAB-03). The authors thank Pfizer Animal Health for a gift of Lutalyse, US Biopsy for
biopsy needles and Susan Jensen for technical assistance.
References
Albrecht, B.A., Macleod, J.N., Daels, P.F., 1997. Differential transcription of steroidogenic enzymes in the equine
primary corpus luteum during diestrus and early pregnancy. Biol. Reprod. 56, 821–829.
Albrecht, B.A., Macleod, J.N., Daels, P.F., 2001. Expression of 3beta-hydroxysteroid dehydrogenase, cytochrome
p450 17alpha-hydroxylase/17, 20-lyase and cytochrome p450 aromatase enzymes in corpora lutea of diestrous
and early pregnant mares. Theriogenology 55, 551–561.
Amri, H., Gaillard, J.L., Altimimi, I., Silberzahn, P., 1993. Equine ovarian aromatase: evidence for a species
specificity. Biochem. Cell Biol. 71, 296–302.
Anderson, L.E., Wu, Y.L., Tsai, S.-J., Wiltbank, M.C., 2001. Prostaglandin F2receptor in the corpus lu-
teum: recent information on gene, messenger ribonucleic acid, and protein. Biol. Reprod. 64, 1041–
1047.
Anderson, L.L., Butcher, R.L., Melampy, R.M., 1961. Subtotal hysterectomy and ovarian function in gilts. En-
docrinology 69, 571–580.
Arosh, J.A., Banu, S.K., Chapdelaine, P., Madore, E., Sirois, J., Fortier, M.A., 2004. Prostaglandin biosynthesis,
transport, and signaling in corpus luteum: a basis for autoregulation of luteal function. Endocrinology 145,
2551–2560.
Auletta, F.J., Caldwell, B.V., Speroff, L., 1976. Estrogen-induced luteolysis in the rhesus monkey: reversal with
indomethacin. Prostaglandins 11, 745–752.
Beling, C.G., Marcus, S.L., Markham, S.M., 1970. Functional activity of corpus luteum following hysterectomy.
J. Clin. Endocr. Metab. 30, 30–39.
284 M.A. Beg et al. / Animal Reproduction Science 90 (2005) 273–285
Bill, C.H., Keys, P.L., 1983. 17 beta-estradiol maintains normal function of corpora lutea throughout pseudo
pregnancy in hypophysectomized rabbits. Biol. Reprod. 28, 608–617.
Bonnin, P., Huynh, L., Haridon, R.L., Chene, N., Martal, J., 1999. Transport of uterine PGF2to the ovaries by
systemic circulation and local lymphovenous-arterial diffusion during luteolysis in sheep. J. Reprod. Fertil.
116, 199–210.
Conley, A.J., Ford, S.P., 1989. Direct luteotrophic effect of oestradiol-17 beta on pig corpora lutea. J. Reprod.
Fertil. 87, 125–131.
Diaz, F.J., Wiltbank, M.C., 2004. Acquisition of luteolytic capacity: changes in prostaglandin F2regula-
tion of steroid hormone receptors and estradiol biosynthesis in pig corpora lutea. Biol. Reprod. 70, 1333–
1339.
Diaz, F.J., Crenshaw, T.D., Wiltbank, M.C., 2000. Prostaglandin F2induces distinct physiological responses in
porcine corpora lutea after acquisition of luteolytic capacity. Biol. Reprod. 63, 1504–1512.
Duffy, D.M., Chaffin, C.L., Stouffer, R.L., 2000. Expression of estrogen receptor alpha and beta in rhesus monkey
corpus luteum during menstrual cycle: regulation by luteinizing hormone and progesterone. Endocrinology
141, 1711–1717.
Ford, S.P., Christenson, L.K., 1991. Direct effects of oestradiol-17 beta and prostaglandin E-2 in protecting pig
corpora lutea from luteolytic dose of prostaglandin F2. J. Reprod. Fertil. 93, 203–209.
Gastal, E.L., Gastal, M.O., Bergfelt, D.R., Ginther, O.J., 1997. Role of diameter differences among follicles in
selection of future dominant follicle in mares. Biol. Reprod. 57, 1320–1327.
Ginther, O.J., 1995. Ultrasonic Imaging and Animal Reproduction: Book 2 Horses. Equiservices Publishing Cross
Plains, WI, USA, pp. 23–88.
Ginther, O.J., 1998. Equine pregnancy: physical interactions between the uterus and conceptus. Proc. Am. Assoc.
Equine Pract. 44, 73–104.
Ginther, O.J., First, N.L., 1971. Maintenance of corpus luteum in hysterectomized mares. Am. J. Vet. Res. 32,
1687–1691.
Guthrie, H.D., Rexroad Jr., C.E., 1980. Blockade of luteal prostaglandin F release in vitro during cloprostenol-
induced luteolysis in pig. Biol. Reprod. 23, 358–362.
Guthrie, H.D., Rexroad Jr., C.E., Bolt, D.J., 1978. In vitro synthesis of progesterone and prostaglandin F by luteal
tissue and prostaglandin F by endometrial tissue from pig. Prostaglandins 16, 433–440.
Guy, M.K., Juengel, J.L., Tandeski, T.R., Niswender, G.D., 1995. Steady state concentrations of mRNA encoding
the receptor for luteinizing hormone during estrous cycle and following prostaglandin F2treatment of ewes.
Endocrine 3, 585–589.
Herschman, H.R., 1994. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis
Rev. 13, 241–256.
Juengel,J.L.,Meberg,B.M., Turzillo, A.M.,Nett,T.M., Niswender, G.D.,1995.Hormonalregulationofmessenger
ribonucleic acid encoding steroidogenic acute regulatory protein in ovine corpora lutea. Endocrinology 136,
5423–5429.
Juengel, J.L., Wiltbank, M.C., Meberg, B.M., Niswender, G.D., 1996. Regulation of steady-state concentrations
of messenger ribonucleic acid encoding prostaglandin F2receptor in ovine corpus luteum. Biol. Reprod. 54,
1096–1102.
Karim, S., Habib, A., Levy-Toledano, S., Maclouf, J., 1996. Cyclooxygenase-1 and -2 of endothelial cells utilize
exogenous or endogenous arachidonic acid for transcellular production of thromboxane. J. Biol. Chem. 271,
12042–12048.
Kot, K., Anderson, L.E., Tsai, S.-J., Wiltbank, M.C., Ginther, O.J., 1999. Transvaginal ultrasound-guided biopsy
of the corpus luteum in cattle. Theriogenology 52, 987–993.
Milvae, R.A., Hansel, W., 1983. Prostacyclin, prostaglandin F2and progesterone production by bovine luteal
cells during estrous cycle. Biol. Reprod. 29, 1063–1068.
Moor, R.M., Rowson, L.E.A., 1966. Local uterine mechanisms affecting luteal function in the sheep. J. Reprod.
Fertil. 11, 307–310.
Neill, J.D., Johansson, E.D.B., Knobil, E., 1969. Failure of hysterectomy to influence the normal pattern of cyclic
progesterone secretion in the rhesus monkey. Endocrinology 84, 464–465.
O’Neill, G.P., Ford, H.A., 1993. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human
tissues. FEBS Lett. 330, 156–160.
M.A. Beg et al. / Animal Reproduction Science 90 (2005) 273–285 285
Olofsson, J.I., Leung, C.H., Bjurulf, E., Ohno, T., Selstam, G., Peng, C., Leung, P.C., 1996. Characterization
and regulation of a mRNA encoding the prostaglandin F2receptor in rat ovary. Mol. Cell. Endocrinol. 123,
45–52.
Rasmussen, F.E., Wiltbank, M.C., Christensen, J.O., Grummer, R.R., 1996. Effects of fenprostalene and oestradiol
17benzoate on parturition and retained placenta in dairy cows and heifers. J. Dairy Sci. 79, 227–234.
Rexroad Jr., C.E., Guthrie, H.D., 1979. Prostaglandin F2 alpha and progesterone release in vitro by ovine luteal
tissue during induced luteolysis. Adv. Exp. Med. Biol. 112, 639–644.
Roser, J.F., Evans, J.W., 1983. Luteal luteinizing hormone receptors during postovulatory period in the mare. Biol.
Reprod. 29, 499–510.
Roser, J.F., Evans, J.W., Mikuckis, G.M., Adams, T.E., Hughes, J.P., 1982. Effect of PGF2on LH receptors in
the equine corpus luteum. J. Reprod. Fertil. Suppl. 32, 235–245.
Stocco, C., 2004. In vivo and in vitro inhibition of cyp19 gene expression by prostaglandin F2in murine luteal
cells: implication of GATA-4. Endocrinology 145, 4957–4966.
Stocco, D.M., Clark, B.J., 1996. Regulation of acute production of steroids in steroidogenic cells. Endocr. Rev.
17, 221–244.
Townson, D.H., Wang, X.J., Keyes, P.L., Kostyo, J.L., Stocco, D.M., 1996. Expression of steroidogenic acute
regulatory protein in corpus luteum of rabbit: dependence upon luteotropic hormone, estradiol-17 beta. Biol.
Reprod. 55, 868–874.
Tsai, S.-J., Wiltbank, M.C., 1997. Prostaglandin F2induces expression of prostaglandin G/H synthase-2 in the
ovine corpus luteum: a potential positive feedback loop during luteolysis. Biol. Reprod. 57, 1016–1022.
Tsai, S.-J., Wiltbank, M.C., 1998. Prostaglandin F2regulates distinct physiological changes in early and mid-
cycle bovine corpora lutea. Biol. Reprod. 58, 346–352.
Tsai, S.-J., Anderson, L.E., Juengel, J., Niswender, G.D., Wiltbank, M.C., 1998. Regulation of prostaglandin F2
and E receptor mRNA by prostaglandin F2in ovine corpora lutea. J. Reprod. Fertil. 114, 69–75.
Tsai, S.-J., Kot, K., Ginther, O.J., Wiltbank, M.C., 2001. Temporal gene expression in bovine corpora lutea after
treatment with PGF2based on serial biopsies in vivo. Reproduction 121, 905–913.
Watson, E.D., Sertich, P.L., 1990. Secretion of prostaglandins and progesterone by cells from corpora lutea of
mares. J. Reprod. Fertil. 88, 223–229.
Watson, E.D., Thomson, S.R.M., Howie, A.F., 2000. Detection of steroidogenic acute regulatory protein in equine
ovaries. J. Reprod. Fertil. 119, 187–192.
Whale, L.J., Eckery, D.C., Juengel, J.L., 2003. Determination of steroidogenic potential of ovarian cells of the
brushtail possum (Trichosurus vulpecula). Biol. Reprod. 69, 947–958.
Wiltbank, J.N., Casida, L.E., 1956. Alterations of ovarian activity by hysterectomy. J. Anim. Sci. 15, 134–140.
Wiltbank, M.C., Ottobre, J.S., 2003. Regulation of intraluteal production of prostaglandins. Reprod. Biol. En-
docrinol. 1, 91–102.
... Biopsies of the CL were collected as described for heifers [30] and mares [37] using an 18-gauge biopsy needle (TLAB TL-18 N, Argon Medical devices, Frisco, TX, USA), stored with 50 μL of RNAlater (Invitrogen, Carlsbad, CA, USA) at 4 • C for ∼24 h then stored at −80 • C until RNA extraction. Endometrial samples were collected immediately after CL biopsy on the uterine horn ipsilateral to the CL using a cytological brush as described for heifers [4] and with minor modification for mares. ...
... In heifers, RPS18 and RPS4X were used as housekeeping genes for endometrial [4] and luteal [39] samples, respectively. For CL and endometrial samples from mares, GAPDH was used as the housekeeping gene [37,40]. ...
... Although both endometrial cytology and luteal biopsy have been performed extensively in each species, this is the first report of in vivo, nonterminal collection of both endometrial and luteal samples for evaluation of gene expression in either heifers/cows or mares for evaluation of the dynamic molecular changes at the same time in each tissue in response to PGF. Refinement of these techniques implemented in this study allowed successful sampling without inducing luteal regression as it occurred in previous reports colleting CL biopsies [37] which was invaluable for successfully testing our hypothesis. Additionally, although the PGF dose used in each species was different, it seemed appropriate to compare the effect of a single minor PGF treatment in the two species owing to the similar decrease in P4 concentrations in the 24 h posttreatment, the lack of a nonphysiologic increase in P4 posttreatment, and the lack of complete luteal regression within 12 of treatment in both heifers and mares. ...
Article
In heifers and mares, multiple pulses of prostaglandin F2alpha (PGF) are generally associated with complete luteal regression. Although PGF pulses occur before and during luteolysis, little is known about the role of minor PGF pulses during preluteolysis on subsequent luteal and endometrial PGF production that may initiate luteolysis. Heifers (n = 7/group) and mares (n = 6/group) were treated with a single minor dose of PGF (3.0 and 0.5 mg, respectively) during mid-luteal phase (12 and 10 days postovulation in heifers and mares, respectively). After treatment, a transient decrease in progesterone (P4) concentrations occurred in heifers between Hours 0–2 but at Hour 4 P4 was not different from pre-treatment. In mares, P4 was unaltered between Hours 0 and 4. Concentrations of P4 decreased in both species by Hour 24 and complete luteolysis occurred in mares by Hour 48. Luteal and endometrial gene expression were evaluated 4 hours post-treatment. In heifers, luteal mRNA abundance of PGF receptor and PGF dehydrogenase were decreased while PTGS2, PGF transporter, and oxytocin receptor were increased. In the heifer endometrium, receptors for oxytocin, P4, and estradiol were upregulated. In mares, luteal expression of PGF receptor was decreased while PGF transporter and oxytocin receptor were increased. The decrease in P4 between Hours 4 and 24 and changes in gene expression were consistent with upregulation of endogenous synthesis of PGF. The hypotheses were supported that a single minor PGF treatment upregulates endogenous machinery for PGF synthesis in heifers and mares stimulating endogenous PGF synthesis through distinct regulatory mechanisms in heifers and mares.
... Transvaginal ultrasound-guided luteal biopsy [30] in PGFtreated mares has been used to study the effects of PGF on the concentrations of mRNA for specific genes in association with luteolysis [31]; mares were treated with PGF on Day 8 and luteal samples were collected by transvaginal biopsy [31]. Treatment with PGF increased the mRNA expression for Cox-2 enzyme indicating that exogenous PGF and presumably endogenous uterine PGF induces the synthesis of intraluteal PGF through an intraluteal loop that augments the luteolytic effect of endometrial PGF in mares. ...
... Transvaginal ultrasound-guided luteal biopsy [30] in PGFtreated mares has been used to study the effects of PGF on the concentrations of mRNA for specific genes in association with luteolysis [31]; mares were treated with PGF on Day 8 and luteal samples were collected by transvaginal biopsy [31]. Treatment with PGF increased the mRNA expression for Cox-2 enzyme indicating that exogenous PGF and presumably endogenous uterine PGF induces the synthesis of intraluteal PGF through an intraluteal loop that augments the luteolytic effect of endometrial PGF in mares. ...
... This more rigid test also did not support the hypothesis that endogenous PGF plays a role in the luteolytic effect of exogenous PGF in mares. These two in vivo tests did not support the findings of (1) an in vitro study that indicated that a PGF auto-amplification system occurs in the endometrium of mares [27], (2) an in vitro study that showed increased PGF production for luteal tissue from mares treated with PGF analogue [51], or (3) an in vivo study of an increase in luteal mRNA for Cox-2 enzyme after treatment of mares with PGF [31]. Further study would be needed to determine the apparent differences between heifers and mares in the mechanisms that underlie luteolysis that could account for the difference between species in the response to exogenous PGF when endogenous PGF is inhibited. ...
Article
An inhibitor of PGF2α biosynthesis (flunixin meglumine, FM) was used to study the role of endogenous PGF2α on the luteolytic effect of exogenous PGF2α in mares. A 2-h infusion of PGF2α at a constant rate (total dose, 0.1 mg) on Day 10 (ovulation = Day 0) was used to mimic the maximal concentrations of a spontaneous pulse of a PGF2α metabolite (PGFM). Treatment with FM (1.7 mg/kg) was done 1 h before and 5 h after the start of PGF2α infusion. In hourly blood samples beginning 1 h before the start of PGF2α infusion, progesterone decreased (P < 0.05) similarly by 5 h in each of the PGF2α and PGF2α+FM groups but not in the controls (n = 5). In a study of spontaneous luteolysis, the same FM dose was given every 6 h from Day 13 until Day 17 or earlier if CL regression was indicated by an 80% decrease in luteal blood-flow signals. Blood was sampled for progesterone assay each day and 8 h of hourly blood sampling was done each day to characterize PGFM concentrations and pulses. Progesterone (P4) was lower (P < 0.05) in controls than in an FM group (n = 7) by Day 15. Luteolysis (P4 < 1 ng/mL) ended on Days 14–19 in individual controls. In contrast, luteolysis did not end until after Day 20 in 4 of 7 FM-treated mares. In the three mares with completion of luteolysis before Day 20 in the FM group, the interval from beginning to end of luteolysis was longer (P < 0.02) (4.5 ± 0.6 days) than in the controls (3.0 ± 0.4 days). During 8-h sessions of hourly blood sampling on Day 14, concentration of PGFM was significantly lower in the FM group for the minimal, mean, and maximal per session. Pulses of PGFM were identified by a CV methodology on each day in 7 of 7 and 3 of 7 mares in the controls and FM group, respectively. The four FM-treated mares without a CV-identified pulse were the four mares in which luteolysis did not occur before Day 20. In mares with detected pulses, PGFM was lower at each nadir and at the peak (86% lower) in the FM group than in controls, but the interval between nadirs or base of a pulse was not different between groups. Hypothesis 1 that endogenous PGF plays a role in the luteolytic effect of exogenous PGF2α was not supported. Hypothesis 2 that an inhibitor of PGF2α biosynthesis prevented or minimized the prominence of PGFM pulses and increased the frequency of persistent CL was supported.
... Overall, the fragment recovery rate was greater with 16G and 18G needles; however, the weight of the ovarian fragments collected with the 16G was greater than that collected with the other two tested needles. An ultrasound-guided transvaginal ovarian biopsy technique has been used previously in several studies with needles of different diameters and lengths to collect tissue and/or ovarian structures (e.g., corpus luteum, ovarian tumors) in women (14G needle [33]; 18G needle [34]), mares (12G needle [1]; 16G needle [12e14, 16,17,19]; 18G and 14G needles [23]), cows (18G needle [4]; 14G needle [35]), and sows (16G needle [6]). The selection of an appropriate needle size (diameter and length) for an ultrasoundguided transvaginal ovarian biopsy procedure depends of the anatomical characteristics inherent to the ovary of each species (e.g., gonadal size and consistency), type of material to be collected (e.g., ovarian stroma, luteal tissue, tumor), and length of the vagina. ...
... The mean weight of the biopsy ovarian fragments harvested ranged from 0.7 to 11.6 mg. Several studies that used the ultrasound-guided BPU approach for ovarian tissue harvesting have reported a range of success in different species (e.g., equine: 72% [12]; bovine: 68% [35]; swine: 50% [6]) as well as within the same species, according to the type of tissue harvested (e.g., equine corpus luteum: 68% [1]; equine ovarian cortex: 86% [19]). The results' variability seems to be associated with intraovarian factors, such as the presence of ovarian structures with different densities [16], and extraovarian factors, such as needle diameter and length, operator training, visualization of the target tissue, and access to ovarian structures [11,12]. ...
Article
Biopsy pick-up (BPU) has been considered a safe method to harvest ovarian fragments from live animals. However, no studies have been reported on the use of BPU to collect in vivo ovarian tissue in goats. The goals of this study were: (i) to test different biopsy needle sizes to collect ovarian tissue in situ using the BPU method (Experiment 1), and (ii) to study ovarian tissue features such as preantral follicle density, morphology, class distribution, and stromal cell density in ovarian fragments obtained in vivo through a laparoscopic BPU method (Experiment 2). In Experiment 1, goat ovaries (n = 20) were collected in a slaughterhouse and subjected to in situ BPU. Three needles (16, 18, and 20G) were tested. In Experiment 2, the most efficient biopsy needle from Experiment 1 was used to perform laparoscopic BPU in goats (n = 8). In Experiment 1, the recovery rate was greater (P < 0.05; range 50-62%) with 16G and 18G needles than the 20G (17%) needle. The mean weight of ovarian fragments collected by the 16G needle was greater (P < 0.05) than the 18G and the 20G needle. In Experiment 2, 62 biopsy attempts were performed and 52 ovarian fragments were collected (90% success rate). Overall, 2054 preantral follicles were recorded in 5882 histological sections analyzed. Mean preantral follicular density was 28.4 ± 1.3 follicles per cm2. The follicular density differed (P < 0.05) among animals and ovarian fragments within the same animal. The mean stromal cell density in the ovarian fragments was 37.1 ± 0.5 cells per 2500 μm2, and differed (P < 0.05) among animals. Moreover, preantral follicle density and stromal cell density were associated (P < 0.001). The percentage of morphologically normal follicles was 70.1 ± 1.2, and differed (P < 0.05) among animals. The majority (79%) of the morphologically normal follicles was classified as primordial follicles, and differed (P < 0.05) among animals and between ovaries. In summary, a laparoscopic BPU method has been developed to harvest ovarian tissue in vivo with a satisfactory success rate in goats. Furthermore, this study described for the first time that goat ovarian biopsy fragments have a high heterogeneity in follicular density, morphology, class distribution, and stromal cell density.
... Complications from TVA are rare but have been previously reported, such as when Velez et al 3 reported that < 0.5% (1/390) of mares developed complications such as ovarian abscess, with the most common complication noted being minor rectal irritation and bleeding during manipulation of the ovaries, causing no long-term effect on ovarian function or fertility. TVLB was first reported in a mare by Beg et al,4 to look at luteal mRNA. Additionally, further research that enrolled 53 mares and involved 183 transvaginal ovarian and/or luteal biopsy procedures found no effect of the TVLB on mare fertility and reported no serious complications besides minimal rectal mucosal bleeding, 5 similar to the findings of Velez et al. 3 To our knowledge, the present report is the first of an ovarian abscess with subsequent adhesion to the left dorsal colon as a complication after TVLB. ...
... Therefore, equine follicles provide an excellent source of materials to validate the in vivo FWB technique, which may be applied later to other species. Furthermore, the larger body size and easy access to the ovaries make the mare an important animal to test transvaginal ultrasound-guided procedures with minimal stress [1][2][3][4][5][6][7][8]46]. Additionally, mares and women have striking similarities in follicle dynamics, ovulation dysfunction, and reproductive aging process [23,30,32,33,47,48]; these reasons reinforced the importance of the use of mares as a model in the present study. ...
Article
Full-text available
Abstract Background In vivo studies involving molecular markers of the follicle wall associated with follicular fluid (FF) milieu are crucial for a better understanding of follicle dynamics. The inability to obtain in vivo samples of antral follicle wall (granulosa and theca cells) without jeopardizing ovarian function has restricted advancement in knowledge of folliculogenesis in several species. The purpose of this study in mares was to develop and validate a novel, minimally invasive in vivo technique for simultaneous collection of follicle wall biopsy (FWB) and FF samples, and repeated collection from the same individual, during different stages of antral follicle development. We hypothesized that the in vivo FWB technique provides samples that maintain the normal histological tissue structure of the follicle wall layers, offers sufficient material for various cellular and molecular techniques, and allows simultaneous retrieval of FF. Methods In Experiment 1 (ex vivo), each follicle was sampled using two techniques: biopsy forceps and scalpel blade (control). In Experiment 2 (in vivo), FWB and FF samples from 10-, 20-, and 30-mm follicles were repeatedly and simultaneously obtained through transvaginal ultrasound-guided technique. Results In Experiment 1, the thickness of granulosa, theca interna, and theca externa layers was not influenced (P > 0.05) by the harvesting techniques. In Experiment 2, the overall recovery rates of FWB and FF samples were 97 and 100%, respectively. However, the success rate of obtaining samples with all layers of the follicle wall and clear FF varied according to follicle size. The expression of luteinizing hormone receptor (LHR) was mostly confined in the theca interna layer, with the estradiol-related receptor alpha (ERRα) in the granulosa and theca interna layers. The 30-mm follicle group had greater (P
... Thus, TGF appears to complement the effects previously seen for Nodal signalling [2], blocking the synthesis and secretion of the luteoprotective factors P4 and PGE2. Initiation of luteolysis in the mare depends on uterine PGF2a [33,34]. Nonetheless, its maintenance relies on intraluteal activation of accessory pathways, which sustain local PGF2a expression and action [8,35]. ...
Article
In the present report we describe the involvement of transforming growth factor B1 (TGF) in functional regression and structural luteolysis in the mare. Firstly, TGF and its receptors activin-like kinase (ALK) 5 and TGF receptor 2 were identified in corpus luteum (CL) steroidogenic, endothelial and fibroblast-like cells. Also, TGF and ALK5 protein expression were shown to be increased in Mid-, and Late-CL (p < 0.05). Subsequently, using an in vitro model with Mid-CL cells, we studied the role of TGF on secretory activity and cell viability. Cell treatment with TGF decreased progesterone (P4) and prostaglandin (PG) E2 concentrations in culture media (p < 0.05), and downregulated mRNA and protein of StAR, CYP11A1, cPGES and mPGES1 (p < 0.05). Conversely, TGF augmented PGF2a concentration in culture media, through PTGS2 and PGFS gene expression activation (p < 0.05). When cells were incubated with PGF2a, both TGF and ALK5 were upregulated (p < 0.05). Additionally, treatment with the pharmacological inhibitor of ALK5, ALK4 and ALK7 - SB431542 (SB) attenuated PGF2a functional and structural luteolytic actions. Indeed, SB blocked: (i) PGF2a inhibitory effect on StAR, CYP11A1, 3BHSD and mPGES1; (ii) PGF2a auto-amplification signal via PTGS2 and PGFS expression (p < 0.05); (iii) the PGF2a-induced BAX and FASL expression (p < 0.05). Finally, TGF decreased cell viability (p < 0.05) and promoted caspase 3 activity (p = 0.08) and the expression of pro-apoptotic FASL and BAX (p < 0.05). Our results suggest that TGF supports functional regression and structural luteolysis, and also confirm the importance of ALK5, ALK4 and ALK7 activation during PGF2a mediated luteolysis in mares.
... Ablation of the largest follicle at the beginning of expected deviation when it reaches 22.5 mm is being used to study the timing of events involved in the conversion of SF to a new DF (experimental or induced deviation) [20]. The transvaginal route can be also used for biopsy of the corpus luteum [21], a section of an antral follicle, or a section of ovarian tissue that may include, for example, preantral follicles [22]. ...
Article
The day of selection of the ovulatory follicle was first observed in any species by an equine practitioner during transrectal palpation in 1926. It was not until 1997 that ultrasonic imaging demonstrated the nature of selection. A wave-stimulating FSH surge reaches a peak on about Day 13 postovulation when the growing follicles are about 13 mm. The FSH declines initially from secretion of inhibin by the multiple growing follicles. After about 2 days, estradiol is secreted by the future dominant follicle (DF) and synergistically contributes to a continuing FSH decline. On about Day 16, the two largest follicles have grown to 23- and 22-mm, respectively, and begin to deviate in growth. The deviation process begins a day before diameter deviation as indicated in the future DF by (1) an increase in intrafollicular estradiol, inhibin A, insulin-like growth factor 1 (IGF1), and vascular endothelial growth factor (VEGF) and (2) changes in echotexture and increased blood flow in the wall of the future DF. The IGF1 increases the sensitivity of the cells of the future DF to the reduced FSH, and VEGF presumably increases the vascular perfusion of the DF wall. The future DF is thus prepared to be the only follicle able to respond to the reduced levels of FSH. Ablation of various follicles at expected deviation indicates that several follicles have dominance capacity. And so, 90 years after the original observation of selection it can be proposed that the deviation process represents the theory of follicle selection in mares.
Article
Our objectives were to examine changes in endometrial and luteal gene expression during estrus, diestrus, pregnancy and treatments to induce luteolysis and putatively induce luteostasis. Groups were: Diestrus (DIEST), Estrus (ESTR), Pregnant (PREG), Oxytocin (OXY), Carbetocin (CARB), and Meclofenamic acid (MFA). Blood was obtained from day (D)12 to D15 for measurement of oxytocinase, also referred to as leucyl-cysteinyl aminopeptidase (LNPEP) and progesterone. Luteal biopsies were obtained on D12 and D15 and an endometrial biopsy on D15. Real-time RT-PCR was performed for the following genes: PGR, ESR1, OXTR, OXT, LNPEP, PTGS2, PTGFR, PLA2G2C, PTGES, SLC2A4, and SLC2A1. Regarding serum LNPEP, PREG and OXY (p-value<0.001) had higher concentrations than DIEST mares. Endometrial PTGES expression was higher (p-value <0.04) in DIEST, PREG and OXY than other groups. Endometrium from ESTR had increased expression of OXT (p-value < 0.02) compared to MFA and OXY mares. Carbetocin treatment: decreased serum progesterone and LNPEP; increased endometrial PLA2G2C; decreased endometrial PTGES; and decreased luteal aromatase and PTGES. Treatment with MFA: decreased endometrial PLA2G2C, increased endometrial PTGES; and resulted in less OXTR and OXT luteal abundance on D12 compared to D15. Endometrial and luteal expression of LNPEP is affected by physiologic stage and treatment and is involved in luteal function and pregnancy recognition pathways through effects on oxytocin and prostaglandin synthesis in the horse.
Article
Full-text available
The estrous cycle or interovulatory interval in the mare allows monitoring and selection of the most appropriate time for copulation or artificial insemination (AI). Estrous cycle is an interaction of hormones of the pineal gland, hypothalamus, pituitary, gonad and endometrium lasting 21 days. The pineal gland secretes melatonin during dark hours. In spring and summer, there is less melatonin secretion, and the hypothalamus secretes gonadotropin-releasing hormone (GnRH) to induce gonadotropins secretion: (FSH, follicle-stimulating hormone, and LH, luteinizing hormone) in the anterior pituitary and stimulates the ovulatory function. FSH promotes follicular growth and LH, follicular maturation and ovulation. Both stimulate the production of estradiol in the ovarian follicles. Estradiol causes estrus signs. After ovulation, the corpus luteum is formed and produces progesterone (P4) for gestation. P4 blocks the hypothalamus and reduces the secretion of GnRH, interrupting the estrous cycle. The hypothalamus produces oxytocin, which is stored in the neurohypophysis (posterior pituitary): and acts on the endometrium, stimulating prostaglandin F2α secretion, to exert luteolysis and the start of a new estrous cycle. In autumn and winter, ovulatory activity is interrupted.
Chapter
Full-text available
Successful pregnancy establishment demands optimal luteal function in mammals. Nonetheless, regression of the corpus luteum (CL) is absolutely necessary for normal female cyclicity. This dichotomy relies on intricate molecular signals and rapidly activated biological responses, such as angiogenesis, extracellular matrix (ECM) remodeling, or programmed cell death. The CL establishment and growth after ovulation depend not only on the luteinizing hormone-mediated endocrine signal but also on a number of auto-, paracrine interactions promoted by cytokines and growth factors like fibroblast growth factor 2, vascular endothelial growth factor A, and tumor necrosis factor α (TNF), which coordinate vascularigenesis and ECM reorganization as well as steroidogenesis. With the organ fully developed, the release of the uterine prostaglandin F2α activates luteolysis, an intricate process supported by intraluteal interactions that ensure the loss of steroidogenic function (functional luteolysis) and the involution of the organ (structural luteolysis). This chapter provides an overview of the local action of cytokines during luteal function, with particular emphasis on the role of TNF and transforming growth factor β superfamilies during luteolysis.
Article
Full-text available
The theory of countercurrent vascular transfer of PGF(2 alpha) during luteolysis was examined. in the first experiment, pulmonary clearance of PGF(2 alpha) was determined to re-examine whether the total amount of PGF(2 alpha) was degraded in the lungs after one passage. Cardiac output was measured by the Fick method and PGF(2 alpha) by radioimmunoassay before and after vascular lung supply, using pulmonary catheterization and the interventional radiology method in ten anaesthetized ewes on day 16 of the oestrous cycle. Cardiac output remained stable (7156 +/- 439 ml min(-1)). Infusion of 5 iu oxytocin resulted in an increase in plasma PGF(2 alpha) concentrations at 30 min in the uterine vein and the pulmonary and femoral arteries (3811 +/- 806, 224 +/- 55 and 18 +/- 4 pg ml(-1), respectively). The PGF(2 alpha) concentrations decreased exponentially and the half-time decreases were 27 (r = 0.99), 16 (r = 0.99) and 18 (r = 0.98) min, respectively. Pulmonary clearance of PGF(2 alpha) was estimated at 6338 +/- 451 ml min(-1). In a second experiment, an arterio-arterial gradient of plasma PGF(2 alpha) concentrations was analysed between the proximal and distal segments of the ovarian artery to verify whether the total amount of PGF(2 alpha) flowing to the ovary was from the local venous-arterial countercurrent pathway. Surgical catheterization techniques were performed on 11 ewes on day 16 of the oestrous cycle. The ovarian arterial blood flow was measured by the implantable Doppler method (8 +/- 1 ml min(-1)). The maximum plasma PGF(2 alpha) concentrations in the femoral and distal ovarian arteries were 23 +/- 6 and 42 +/- 11 pg ml(-1)(P < 0.05), respectively. Plasma PGF(2 alpha) decreased exponentially in the femoral artery and the halftime decrease was 26 min (u = 0.98), and in the distal ovarian artery close to the ovary PGF(2 alpha) decreased linearly and the half-time decrease was 108 min (r = 0.96). Consequently, the arterio-arterial diffusion gradient of PGF(2 alpha) concentrations was extended to 3 h. These experiments showed that the PGF(2 alpha) flow rate in the pulmonary artery was 42.275 +/- 10.793 mu g per 150 min (n = 10) and the systemic arterial PGF(2 alpha) flow rate was 5.359 +/- 1.658 mu g per 150 min (n = 10). Therefore, 12% of the PGF(2 alpha) was not oxidized by the lungs. The proximal ovarian PGF(2 alpha) flow rate was 6.909 +/- 2.341 ng per 150 min, while the distal flow rate was 21.003 +/- 5.703 ng per 150 min (n = 11). Thus, 33% of the PGF(2 alpha) was transported rapidly to the ovary via the systemic route, while 67% was transported by slow local countercurrent diffusion, which extended the duration of luteolytic activity to four times that of the PGF(2 alpha) surge. These results indicate both rapid systemic transport of PGF(2 alpha) to the ovaries and a slower buffer mechanism involving a local diffusion pathway, rather than a direct countercurrent system.
Article
Full-text available
Five gilts each received intraluteal implants releasing about 4.4 ± 1.1 (Group 1), 15.0 ± 1.1 (Group 2) or 22.4 ± 1.0 (Group 3) μg oestradiol/day as determined by in-vitro incubation of implants of similar weight and oestradiol content. On Day 11 of the oestrous cycle (Day 0 = first day of oestrus), 3 CL in one ovary received oestradiol implants, 3 CL in the other ovary received vehicle implants, and all other CL in both ovaries served as uninjected control CL. An additional group of 6 animals served as controls and included 4 animals receiving bilateral vehicle implants (3 CL per ovary) on Day 11 and 2 unoperated gilts. All animals were slaughtered on Day 19 of their oestrus cycle, and the weight, progesterone content and concentration of each CL were determined. In Group 3 gilts, luteal weight, progesterone content and concentration were greater by 68.7 ± 24.0 mg, 6.54 ± 1.33 μg and 7.54 ± 2.00 ng/ml respectively (P < 0.01) in oestradiol-implanted CL than in vehicle-implanted CL, which appeared to be similar to uninjected control CL. No differences were seen between oestradiol-17β and vehicle-treated CL in CL from gilts in Groups 1 or 2. All CL of Group 3 gilts were heavier and contained a greater content and concentration of progesterone (P < 0.01) than gilts in Groups 1 and 2, and in controls for which the values were similar. These results demonstrate that exogenous oestradiol can directly stimulate the growth of an individual CL; however, the oestradiol release rate must be high enough to maintain all CL bilaterally before this effect is seen.
Article
Full-text available
There are conflicting reports on the presence or absence of estrogen receptor (ER) in the primate corpus luteum, and the discovery of a second type of estrogen receptor, ERb, adds an additional level of complexity. To reevaluate ER expression in the primate luteal tissue, we used semiquantitative RT-PCR based assays and Western blotting to assess ERa and b messenger RNA (mRNA) and protein levels in corpora lutea (n 5 3/stage) obtained from adult female rhesus mon- keys at early (days 3-5), mid (days 6 - 8), mid-late (days 10 -12), and late (days 14 -16) luteal phase of the natural menstrual cycle. ERa mRNA levels did not vary across the stages of the luteal phase, and ERa protein was not consistently detected in luteal tissues. However, ERb mRNA and protein levels were detectable in early and mid luteal phases and increased (P , 0.05) to peak levels at mid-late luteal phase before declining by late luteal phase. To determine if ERb mRNA expression in the corpus luteum is regulated by LH, monkeys received the GnRH antagonist antide either alone or with 3 daily injections of LH to simulate pulsatile LH release. Treatment with antide alone or concomitant LH administration did not alter luteal ERb mRNA lev- els. When monkeys also received the 3b-hydroxysteroid dehydroge- nase inhibitor trilostane to reduce luteal progesterone production, luteal ERb mRNA levels were 3-fold higher (P , 0.05) than in mon- keys receiving antide 1 LH only. Replacement of progestin activity with R5020 reduced luteal ERb mRNA levels to those seen in animals receiving antide 1 LH. Thus, there is dynamic ERb expression in the primate corpus luteum during the menstrual cycle, consistent with a role for estrogen in the regulation of primate luteal function and life span via a receptor (ERb)-mediated pathway. Increased ERb expres- sion in the progestin-depleted corpus luteum during LH exposure suggests that the relative progestin deprivation experienced by the corpus luteum between LH pulses may enhance luteal sensitivity to estrogens during the late luteal phase of the menstrual cycle. (En- docrinology 141: 1711-1717, 2000)
Article
To investigate the regulation of ovine luteal receptors for prostaglandin F2 alpha (PGF2 alpha), reverse transcription-polymerase chain reaction was used to produce a 284-bp partial cDNA that was 98% identical to that reported for the bovine PGF2 alpha receptor (PGF2 alpha-R). In situ hybridization localized mRNA for PGF2 alpha-R specifically to large luteal cells. In experiment 1, pools of luteal tissue (n = 4/day) collected from ewes on Days 3, 6, 9, 12, and 15 of the estrous cycle were analyzed for mRNA encoding PGF2 alpha-R. There was no difference in mean steady-state concentrations of mRNA encoding PGF2 alpha-R among any of the days studied (range = 2.3 +/- 0.3 to 3.5 +/- 0.7 fmol PGF2 alpha-R mRNA/ microgram poly[A]+ RNA as assessed by slot-blot hybridization). In experiment 2, ewes on Day 11 or Day 12 of the estrous cycle were administered PGF2 alpha, and corpora lutea were collected 4, 12, or 24 h later (n = 4-5 per time point). Nontreated (n = 4) or saline-treated (n = 4) ewes served as controls. Luteal concentrations of mRNA encoding PGF2 alpha-R were decreased (p < 0.05) at 4, 12, and 24 h after injection of PGF2 alpha. In experiment 3, ewes (midluteal phase) were administered saline, PGF2 alpha, phorbol 12-myristate 13-acetate (PMA), or LH via ovarian arterial injection, and luteal tissue was collected 0, 4, 12, or 24 h later (n = 3-4 per treatment per time). Steady-state concentrations of mRNA encoding PGF2 alpha-R were decreased (p < 0.05) by PGF2 alpha and PMA treatment (4 and 12 h) but were increased (p < 0.05) at 24 h after LH treatment. In summary, 1) mRNA encoding PGF2 alpha-R was localized to large luteal cells; 2) concentrations of mRNA encoding PGF2 alpha-R did not vary during the estrous cycle; 3) treatment with PGF2 alpha or PMA to activate protein kinase C decreased concentrations of PGF2 alpha-R mRNA within 4 h of treatment; and 4) administration LH increased concentrations of mRNA encoding PGF2 alpha-R 24 h following injection.
Article
The rate-limiting step in the formation of prostanoids is the conversion of arachidonic acid to prostaglandin H-2 by cyclooxygenase, also known as prostaglandin G/H synthase/cyclooxygenase. Two forms of cyclooxygenase have been characterized: a ubiquitously expressed form (COX-1) and a recently described second form (COX-2) inducible by various factors including mitogens, hormones, serum and cytokines. Here we quantitate by the reverse transcriptase-polymerase chain reaction (RT-PCR) the expression of COX-1 and COX-2 mRNA in human tissues including lung, uterus, testis, brain, pancreas, kidney, liver, thymus, prostate, mammary gland, stomach and small intestine. All tissues examined contained both COX-1 and COX-2 mRNA and could be grouped according to the level of COX mRNA expression. The highest levels of COX mRNAs were detected in the prostate where approximately equal levels of COX-1 and COX-2 transcripts were present. In the lung high levels of COX-2 were observed whereas COX-1 mRNA levels were about 2-fold lower. An intermediate level of expression of both COX-1 and COX-2 mRNA was observed in the mammary gland, stomach, small intestine, and uterus. The lowest levels of COX-1 and COX-2 mRNA were observed in the testis, pancreas, kidney, liver, thymus, and brain.
Article
In pregnant mares, eCG stimulates luteal androgen and estrogen production, increasing plasma concentrations 2- to 3-fold. To study how these changes are regulated, we examined the expression of mRNA for the steroidogenic enzymes 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD), cytochrome P450 17 alpha-hydroxylase/17,20-lyase (P450 17 alpha), and cytochrome P450 aromatase (P450arom) in equine primary corpora lutea using Northern blot analyses. Three equine specific cDNAs were generated by reverse transcriptase polymerase chain reaction. When compared to human, bovine, and rat sequences, the nucleotide identities were 82%, 84%, and 76%, respectively, for 3 beta-HSD cDNA (843 base pairs [bp]); 79%, 80% and 66% for P450(17) alpha cDNA (541 bp); and 80%, 83% and 75% for P450arom cDNA (289 bp). The P450(17) alpha cDNA sequence demonstrated 99.6% nucleotide identity with the previously published sequence for equine testicular P450(17) alpha. Luteal tissue samples were collected at three times: diestrus (Days 8-10), early pregnancy before the onset of eCG secretion (Days 29-35), and early pregnancy after the onset of eCG secretion (Days 42-45). Although no significant changes were observed in 3 beta-HSD expression, P450(17) alpha and P450arom demonstrated stage-specific transcriptional regulation. Steady-state levels of P450(17) alpha mRNA were similar during diestrus and early pregnancy before the onset of eCG secretion but increased significantly after the onset of eCG secretion. Cytochrome P450arom mRNA levels decreased significantly after the onset of eCG secretion. Steady-state levels of P450arom mRNA were highest in luteal tissue collected during pregnancy before the onset of eCG secretion and intermediate during diestrus. Secretion of eCG appears to increase luteal estrogen synthesis by a transcriptional up-regulation of P450(17) alpha expression. These data suggest that availability of aromatizable androgens may be rate-limiting in luteal estrogen synthesis before the onset of eCG secretion.
Article
The recent characterization of the mitochondrial protein, Steroidogenic Acute Regulatory (StAR) protein, as a rate-limiting protein in steroidogenesis prompted us to investigate whether StAR is expressed in the rabbit corpus luteum and whether the expression of StAR is responsive to estradiol-17 beta, the luteotropic hormone in the rabbit. In rabbits treated continuously with exogenous estradiol through Day 13 of pseudopregnancy (n = 9), immunoblot analysis revealed that luteal expression of StAR was stable, ranging from 8.5 to 9.7 U of corrected integrated optical density. Plasma progesterone concentration (mean +/- SEM) remained elevated in these rabbits (14.3 +/- 2.1 ng/ml). In contrast, expression of StAR decreased in corpora lutea of rabbits deprived of estradiol for the last 48 and 72 h of the experiment (4.9 +/- 2.2 and 0.3 +/- 0.2 U, respectively, n = 3 per group), and was associated with a decline in plasma progesterone (0.8 +/- 0.1 and 0.5 +/- 0.3 ng/ml, respectively). Replacement of estradiol after 48 h of estradiol deprivation (n = 3) stimulated the reappearance of StAR (10.3 +/- 2.6 U) and the restoration of plasma progesterone (10.4 +/- 4.9 ng/ml). [35S]Methionine labeling of proteins in rabbit corpora lutea revealed that several isoforms of StAR protein were specifically synthesized in response to estradiol treatment. Collectively, these observations are consistent with a proposed role for StAR in the mediation of the luteotropic effect of estrogen to promote the synthesis of progesterone in the rabbit.
Article
The prostaglandin (PG) F2α receptor (FPr) in the corpus luteum is essential for maintaining normal reproductive cyclicity in many species. Activation of this seven-transmembrane spanning receptor at the end of the cycle leads to a decrease in progesterone and the demise of the corpus luteum (luteolysis). Recently, the gene structure of the FPr in three mammalian species has been elucidated; however, promoter regulation of the gene is still poorly understood. The FPr mRNA is extremely low in steroidogenic follicular cells (theca or granulosa) but is expressed at high levels in the corpus luteum, particularly in the large luteal cells. Treatment with PGF2α decreased FPr mRNA expression in luteal cells in most species that have been studied. Key amino acids have been suggested to be critical for binding of FPr to PGF2α based on three-dimensional modeling and comparisons with other G-protein-coupled receptors. Moieties of the PGF2α molecule that are essential for binding or specificity of binding to the FPr have been identified by radioreceptor binding studies. In this article, recent information is reviewed on the structure of the FPr gene, regulation of luteal FPr mRNA, and receptor/ligand interaction requirements for the FPr protein.